Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Accuray radiotherapy dose calculation software:

This article was originally published in Clinica

Executive Summary

Accuray has received 510(k) clearance from the US FDA for its dose calculation software for radiotherapy. The technology - called the Monte Carlo Dose calculation algorithm - is now available for sale worldwide, reported the company. Traditional dose calculation methods assume all photons take a single path and therefore use a single calculation to represent the dose delivered by all photons. The Monte Carlo method, however, takes into account interactions of each individual photon when considering an appropriate dose. The Sunnyvale, California firm claims it will be the first company to market the technology. The product was launched at the 9th Biennial European Society for Therapeutic Radiology and Oncology (ESTRO) meeting in Barcelona, Spain, during September 8-13.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049680

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel